These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 19308069)

  • 1. Parallel progression of primary tumours and metastases.
    Klein CA
    Nat Rev Cancer; 2009 Apr; 9(4):302-12. PubMed ID: 19308069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.
    Stoecklein NH; Klein CA
    Int J Cancer; 2010 Feb; 126(3):589-98. PubMed ID: 19795462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].
    Klein CA
    Verh Dtsch Ges Pathol; 2003; 87():158-64. PubMed ID: 16888908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and adaptation during metastatic cancer progression.
    Klein CA
    Nature; 2013 Sep; 501(7467):365-72. PubMed ID: 24048069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using tumour phylogenetics to identify the roots of metastasis in humans.
    Naxerova K; Jain RK
    Nat Rev Clin Oncol; 2015 May; 12(5):258-72. PubMed ID: 25601447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated molecular and clinical staging defines the spectrum of metastatic cancer.
    Pitroda SP; Weichselbaum RR
    Nat Rev Clin Oncol; 2019 Sep; 16(9):581-588. PubMed ID: 31092903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gene regulatory networks in promoting cancer progression and metastasis.
    Coghlin C; Murray GI
    Future Oncol; 2014 Apr; 10(5):735-48. PubMed ID: 24799055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systemic progression of human cancer: a focus on the individual disseminated cancer cell--the unit of selection.
    Klein CA
    Adv Cancer Res; 2003; 89():35-67. PubMed ID: 14587870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.
    Romano S; D'Angelillo A; Romano A; Nappo G; Romano MF
    Curr Med Chem; 2014; 21(14):1631-8. PubMed ID: 23992331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.
    Brabletz T; Jung A; Spaderna S; Hlubek F; Kirchner T
    Nat Rev Cancer; 2005 Sep; 5(9):744-9. PubMed ID: 16148886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-metastatic niches: organ-specific homes for metastases.
    Peinado H; Zhang H; Matei IR; Costa-Silva B; Hoshino A; Rodrigues G; Psaila B; Kaplan RN; Bromberg JF; Kang Y; Bissell MJ; Cox TR; Giaccia AJ; Erler JT; Hiratsuka S; Ghajar CM; Lyden D
    Nat Rev Cancer; 2017 May; 17(5):302-317. PubMed ID: 28303905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concepts of metastasis in flux: the stromal progression model.
    Sleeman JP; Christofori G; Fodde R; Collard JG; Berx G; Decraene C; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):174-86. PubMed ID: 22374376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contributions of cancer cell metabolism to metastasis.
    Pascual G; Domínguez D; Benitah SA
    Dis Model Mech; 2018 May; 11(8):. PubMed ID: 29739810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
    Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
    Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.
    Tellez-Gabriel M; Ory B; Lamoureux F; Heymann MF; Heymann D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sleeping ugly: Tumour microenvironment's act to make or break the spell of dormancy.
    Gay LJ; Malanchi I
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):231-238. PubMed ID: 28501561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal functional driver gene heterogeneity among untreated metastases.
    Reiter JG; Makohon-Moore AP; Gerold JM; Heyde A; Attiyeh MA; Kohutek ZA; Tokheim CJ; Brown A; DeBlasio RM; Niyazov J; Zucker A; Karchin R; Kinzler KW; Iacobuzio-Donahue CA; Vogelstein B; Nowak MA
    Science; 2018 Sep; 361(6406):1033-1037. PubMed ID: 30190408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein glycosylation in cancer metastasis.
    Oliveira-Ferrer L; Legler K; Milde-Langosch K
    Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic insights into the morass of metastatic heterogeneity.
    Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
    Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics.
    Klein CA; Hölzel D
    Cell Cycle; 2006 Aug; 5(16):1788-98. PubMed ID: 16929175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.